Phase I trial of oral mTOR inhibitor everolimus in combination with trastuzumab and vinorelbine in pre-treated patients with HER2-overexpressing metastatic breast cancer
Titel:
Phase I trial of oral mTOR inhibitor everolimus in combination with trastuzumab and vinorelbine in pre-treated patients with HER2-overexpressing metastatic breast cancer
Auteur:
Jerusalem, Guy Fasolo, Angelica Dieras, Veronique Cardoso, Fatima Bergh, Jonas Vittori, Luc Zhang, Yufen Massacesi, Cristian Sahmoud, Tarek Gianni, Luca